{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:09:13Z","timestamp":1789506553548,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,15]]},"DOI":"10.7759\/cureus.116316","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:25:00Z","timestamp":1789503900000},"source":"Crossref","is-referenced-by-count":0,"title":["Sickle Cell Disease in Latin America and the Caribbean: Where the Care Cascade Breaks Down"],"prefix":"10.7759","author":[{"given":"Mar\u00eda Betzabeth","family":"Orozco Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan David","family":"Urrea Ospina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Felipe","family":"Facundo Solarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Jimena","family":"Oviedo Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Sof\u00eda","family":"Montealegre Neiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Paula","family":"Salazar Cede\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngel","family":"Zarama Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan David","family":"Gomez Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jose","family":"Martinez Pe\u00f1aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","year":"2023","unstructured":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021. a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol. 2023, 10:e585-99. 10.1016\/S2352-3026(23)00118-7","journal-title":"Lancet Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga KI","year":"2017","unstructured":"Ataga KI, Kutlar A, Kanter J, et al.. Crizanlizumab for the prevention of pain crises in sickle cell disease. N Engl J Med. 2017, 376:429-39. 10.1056\/NEJMoa1611770","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023301","article-title":"An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease","volume":"143","author":"Kassim AA","year":"2024","unstructured":"Kassim AA, de la Fuente J, Nur E, et al.. An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease. Blood. 2024, 143:2654-65. 10.1182\/blood.2023023301","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams RJ","year":"1998","unstructured":"Adams RJ, McKie VC, Hsu L, et al.. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998, 339:5-11. 10.1056\/NEJM199807023390102","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21960","article-title":"Covid-19 impacts: ethnic and regional inequalities in sickle cell disease patient care in Brazil","volume":"9","author":"Santos RL","year":"2023","unstructured":"Santos RL, Rodrigues W, Prata D, Trevisan DM, Bermejo PH, Moreira MF. Covid-19 impacts: ethnic and regional inequalities in sickle cell disease patient care in Brazil. Heliyon. 2023, 9:e21960. 10.1016\/j.heliyon.2023.e21960","journal-title":"Heliyon"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008938","article-title":"Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence","volume":"7","author":"Can\u00e7ado RD","year":"2023","unstructured":"Can\u00e7ado RD, Costa FF, Lobo C, et al.. Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence. Blood Adv. 2023, 7:3783-92. 10.1182\/bloodadvances.2022008938","journal-title":"Blood Adv"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bglo.2025.100032","article-title":"Neurocognitive functioning of patients with sickle cell disease in low- and middle-income countries","volume":"1","author":"Pinkett B","year":"2025","unstructured":"Pinkett B, Nesbitt K, Rooney E, et al.. Neurocognitive functioning of patients with sickle cell disease in low- and middle-income countries. Blood Glob Hematol. 2025, 1:10.1016\/j.bglo.2025.100032","journal-title":"Blood Glob Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-026-04475-3","article-title":"Mortality trends and socioeconomic inequalities in sickle cell disease in Colombia, 2012-2023: a population-based study","author":"Palacios-Barahona U","year":"2026","unstructured":"Palacios-Barahona U, Combariza JF. Mortality trends and socioeconomic inequalities in sickle cell disease in Colombia, 2012-2023: a population-based study. Orphanet J Rare Dis. 2026, 10.1186\/s13023-026-04475-3","journal-title":"Orphanet J Rare Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1590\/0102-311XEN256421","article-title":"Social inequalities in the temporal trend of mortality from sickle cell disease in Brazil, 1996-2019","volume":"39","author":"Cordovil K","year":"2023","unstructured":"Cordovil K, Tassinari W, Oliveira RV, H\u00f6kerberg Y. Social inequalities in the temporal trend of mortality from sickle cell disease in Brazil, 1996-2019. Cad Saude Publica. 2023, 39:e00256421. 10.1590\/0102-311XEN256421","journal-title":"Cad Saude Publica"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jped.2014.08.006","article-title":"Characterization of mortality in children with sickle cell disease diagnosed through the Newborn Screening Program","volume":"91","author":"Sabarense AP","year":"2015","unstructured":"Sabarense AP, Lima GO, Silva LM, Viana MB. Characterization of mortality in children with sickle cell disease diagnosed through the Newborn Screening Program. J Pediatr (Rio J). 2015, 91:242-7. 10.1016\/j.jped.2014.08.006","journal-title":"J Pediatr (Rio J)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijns5010005","article-title":"Newborn screening for sickle cell disease in the Caribbean: an update on the current situation and disease prevalence","volume":"5","author":"Knight-Madden J","year":"2019","unstructured":"Knight-Madden J, Lee K, Elana G, et al.. Newborn screening for sickle cell disease in the Caribbean: an update on the current situation and disease prevalence. Int J Neonatal Screen. 2019, 5:5. 10.3390\/ijns5010005","journal-title":"Int J Neonatal Screen"},{"key":"ref12","unstructured":"Technical report. neonatal screening repository 2024. (2025). Accessed: August 20, 2026: https:\/\/www.ins.gov.co\/BibliotecaDigital\/informe-tecnico-repositorio-de-tamizaje-neonatal-2024.pdf."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046240","article-title":"Cross-sectional prospective feasibility study of newborn screening for sickle cell anaemia and congenital hypothyroidism in Guyana","volume":"12","author":"Alladin BA","year":"2022","unstructured":"Alladin BA, Mohamed-Rambaran P, Grey V, et al.. Cross-sectional prospective feasibility study of newborn screening for sickle cell anaemia and congenital hypothyroidism in Guyana. BMJ Open. 2022, 12:e046240. 10.1136\/bmjopen-2020-046240","journal-title":"BMJ Open"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjhh.2014.05.001","article-title":"Follow-up of children with hemoglobinopathies diagnosed by the Brazilian Neonatal Screening Program in the state of Pernambuco","volume":"36","author":"Soares AC","year":"2014","unstructured":"Soares AC, Samico IC, Ara\u00fajo AS, Bezerra MA, Hatzlhofer BL. Follow-up of children with hemoglobinopathies diagnosed by the Brazilian Neonatal Screening Program in the state of Pernambuco. Rev Bras Hematol Hemoter. 2014, 36:250-5. 10.1016\/j.bjhh.2014.05.001","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010104","article-title":"Implementation of hospital-based sickle cell newborn screening and follow-up programs in Haiti","volume":"8","author":"Alvarez OA","year":"2024","unstructured":"Alvarez OA, St Victor D\u00e9ly N, Paul Hanna M, et al.. Implementation of hospital-based sickle cell newborn screening and follow-up programs in Haiti. Blood Adv. 2024, 8:14-22. 10.1182\/bloodadvances.2023010104","journal-title":"Blood Adv"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2026.106458","article-title":"Variations in transcranial doppler among pediatric patients with sickle cell disease in the Brazilian Northeast: a cross-sectional study","volume":"48","author":"de Oliveira Castro Marques TR","year":"2026","unstructured":"de Oliveira Castro Marques TR, Vidal SA, da Costa HA, Souza AI. Variations in transcranial doppler among pediatric patients with sickle cell disease in the Brazilian Northeast: a cross-sectional study. Hematol Transfus Cell Ther. 2026, 48:106458. 10.1016\/j.htct.2026.106458","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15462","article-title":"Clinical and genetic ancestry profile of a large multi-centre sickle cell disease cohort in Brazil","volume":"182","author":"Carneiro-Proietti AB","year":"2018","unstructured":"Carneiro-Proietti AB, Kelly S, Miranda Teixeira C, et al.. Clinical and genetic ancestry profile of a large multi-centre sickle cell disease cohort in Brazil. Br J Haematol. 2018, 182:895-908. 10.1111\/bjh.15462","journal-title":"Br J Haematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-020-01504-5","article-title":"Screening for sickle cell disease in newborns: a systematic review","volume":"9","author":"Runkel B","year":"2020","unstructured":"Runkel B, Kl\u00fcppelholz B, Rummer A, et al.. Screening for sickle cell disease in newborns: a systematic review. Syst Rev. 2020, 9:250. 10.1186\/s13643-020-01504-5","journal-title":"Syst Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijns10020038","article-title":"Current status of newborn bloodspot screening worldwide in 2024: a comprehensive review of recent activities (2020-2023)","volume":"10","author":"Therrell BL","year":"2024","unstructured":"Therrell BL, Padilla CD, Borrajo GJ, et al.. Current status of newborn bloodspot screening worldwide in 2024: a comprehensive review of recent activities (2020-2023). Int J Neonatal Screen. 2024, 10:10.3390\/ijns10020038","journal-title":"Int J Neonatal Screen"},{"key":"ref20","unstructured":"Resolution 117 of 2026, updating technical annex 1 of resolution 207 of 2024 on the neonatal screening program. (2026). Accessed. August 20, 2026: https:\/\/www.minsalud.gov.co\/Normatividad_Nuevo\/Resolucion%20No%20117%20de%202026.pdf."},{"key":"ref21","unstructured":"Law No. 14-24 on the conduct of neonatal screening tests. (2024). Accessed. August 20, 2026: https:\/\/www.consultoria.gov.do\/Consulta\/Home\/FileManagement?documentId=3402163&managementType=1."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014327","article-title":"Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial","volume":"9","author":"Nieves RM","year":"2025","unstructured":"Nieves RM, Latham T, Marte N, et al.. Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial. Blood Adv. 2025, 9:1791-800. 10.1182\/bloodadvances.2024014327","journal-title":"Blood Adv"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2025.103964","article-title":"Updating the Brazilian clinical practice guidelines for sickle cell disease: recommendations and development process","volume":"47","author":"Gargano LP","year":"2025","unstructured":"Gargano LP, Fachi MM, Oliveira LA, et al.. Updating the Brazilian clinical practice guidelines for sickle cell disease: recommendations and development process. Hematol Transfus Cell Ther. 2025, 47:103964. 10.1016\/j.htct.2025.103964","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14323","article-title":"Real-world evidence of crizanlizumab showing reductions in vaso-occlusive crises and opioid usage in sickle cell disease","volume":"114","author":"DeBonnett L","year":"2025","unstructured":"DeBonnett L, Joshi V, Silva-Pinto AC, et al.. Real-world evidence of crizanlizumab showing reductions in vaso-occlusive crises and opioid usage in sickle cell disease. Eur J Haematol. 2025, 114:293-302. 10.1111\/ejh.14323","journal-title":"Eur J Haematol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2025.01007","article-title":"Evaluation of pharmacotherapy in sickle cell disease in an Afro-Colombian community: a cross-sectional analytical study in San Basilio de Palenque, Bol\u00edvar","volume":"14","author":"Ahumada L","year":"2025","unstructured":"Ahumada L, Alviz A, Gonzalez T, Gomez G. Evaluation of pharmacotherapy in sickle cell disease in an Afro-Colombian community: a cross-sectional analytical study in San Basilio de Palenque, Bol\u00edvar. Intractable Rare Dis Res. 2025, 14:122-7. 10.5582\/irdr.2025.01007","journal-title":"Intractable Rare Dis Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282X20160175","article-title":"Patients with sickle cell disease are frequently excluded from the benefits of transcranial doppler screening for the risk of stroke despite extensive and compelling evidence","volume":"75","author":"Rodrigues DL","year":"2017","unstructured":"Rodrigues DL, Adegoke SA, Campos RS, Braga JA, Figueiredo MS, Silva GS. Patients with sickle cell disease are frequently excluded from the benefits of transcranial doppler screening for the risk of stroke despite extensive and compelling evidence. Arq Neuropsiquiatr. 2017, 75:15-9. 10.1590\/0004-282X20160175","journal-title":"Arq Neuropsiquiatr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jped.2017.09.010","article-title":"Clinical and hematological profile in a newborn cohort with hemoglobin SC","volume":"94","author":"Rezende PV","year":"2018","unstructured":"Rezende PV, Santos MV, Campos GF, et al.. Clinical and hematological profile in a newborn cohort with hemoglobin SC. J Pediatr (Rio J). 2018, 94:666-72. 10.1016\/j.jped.2017.09.010","journal-title":"J Pediatr (Rio J)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24198","article-title":"Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: a Phase III international randomized clinical trial","volume":"90","author":"Hankins JS","year":"2015","unstructured":"Hankins JS, McCarville MB, Rankine-Mullings A, et al.. Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: a Phase III international randomized clinical trial. Am J Hematol. 2015, 90:1099-105. 10.1002\/ajh.24198","journal-title":"Am J Hematol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1590\/0100-3984.2025.0090","article-title":"Pre-transplant imaging evaluation in sickle cell disease: recommended protocols before allogeneic hematopoietic stem cell transplantation","volume":"59","author":"Xavier FD","year":"2026","unstructured":"Xavier FD, da Silva MO, Pereira LH, Seber A, Duarte ML. Pre-transplant imaging evaluation in sickle cell disease: recommended protocols before allogeneic hematopoietic stem cell transplantation. Radiol Bras. 2026, 59:e20250090. 10.1590\/0100-3984.2025.0090","journal-title":"Radiol Bras"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6359871","article-title":"Laboratory and genetic biomarkers associated with cerebral blood flow velocity in hemoglobin SC disease","volume":"2017","author":"Santiago RP","year":"2017","unstructured":"Santiago RP, Vieira C, Adanho CS, et al.. Laboratory and genetic biomarkers associated with cerebral blood flow velocity in hemoglobin SC disease. Dis Markers. 2017, 2017:6359871. 10.1155\/2017\/6359871","journal-title":"Dis Markers"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.537415","article-title":"Brain magnetic resonance imaging abnormalities in adult patients with sickle cell disease: correlation with transcranial Doppler findings","volume":"40","author":"Silva GS","year":"2009","unstructured":"Silva GS, Vicari P, Figueiredo MS, Carrete H Jr, Idagawa MH, Massaro AR. Brain magnetic resonance imaging abnormalities in adult patients with sickle cell disease: correlation with transcranial Doppler findings. Stroke. 2009, 40:2408-12. 10.1161\/STROKEAHA.108.537415","journal-title":"Stroke"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2021.05.001","article-title":"Follow-up of children with sickle cell anemia screened with transcranial Doppler and enrolled in a primary prevention program of ischemic stroke","volume":"44","author":"Sabarense AP","year":"2022","unstructured":"Sabarense AP, Silva CM, Muniz MB, Viana MB. Follow-up of children with sickle cell anemia screened with transcranial Doppler and enrolled in a primary prevention program of ischemic stroke. Hematol Transfus Cell Ther. 2022, 44:478-84. 10.1016\/j.htct.2021.05.001","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bglo.2025.100040","article-title":"Hydroxyurea therapy in sickle cell disease: evaluating healthcare costs and utilization in a Brazilian tertiary setting","author":"Browne LL","year":"2025","unstructured":"Browne LL, do Nascimento EM, Moura P, et al.. Hydroxyurea therapy in sickle cell disease: evaluating healthcare costs and utilization in a Brazilian tertiary setting. Blood Glob Hematol. 2025, 10.1016\/j.bglo.2025.100040","journal-title":"Blood Glob Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/531220-sickle-cell-disease-in-latin-america-and-the-caribbean-where-the-care-cascade-breaks-down","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:25:04Z","timestamp":1789503904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/531220-sickle-cell-disease-in-latin-america-and-the-caribbean-where-the-care-cascade-breaks-down"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.116316","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}